Cytomegalovirus shedding in the oral cavity of allogeneic haematopoietic stem cell transplant patients

Oral Diseases

Volumn 13, Issue 2, 2007, Pages 163-169

  Correia Silva, J De F ^a   Victoria J M N ^a   Guimaraes A L S ^a   Salomao U E ^a   De Abreu, M H N G ^a   Bittencourt, H ^b   Gomez, R S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b STATE UNIVERSITY OF MONTES CLAROS   (Brazil)

Author keywords

Cytomegalovirus; Cytomegalovirus shedding; Haematopoietic stem cell transplantation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; PREDNISONE;

ADULT; AGE DISTRIBUTION; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; KAPLAN MEIER METHOD; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MOUTH INFECTION; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SALIVA ANALYSIS; SEX DIFFERENCE; SURVIVAL; SYSTEMATIC REVIEW; THROMBOCYTE COUNT; VIRUS DETECTION; VIRUS SHEDDING;

ADOLESCENT; ADULT; AGE FACTORS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MOUTH DISEASES; MOUTH MUCOSA; PLATELET COUNT; SALIVA; SALIVARY GLAND DISEASES; SEX FACTORS; SURVIVAL RATE; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; VIRUS SHEDDING;

EID: 33846941508     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2006.01240.x     Document Type: Article

References (37)

1. Ammatuna P, Campisi G, Giovannelli L et al (2001). Presence of Epstein-Barr virus, cytomegalovirus and human papillomavirus in normal oral mucosa of HIV-infected and renal transplant patients. Oral Dis 7: 34-40.
2. Asano-Mori Y, Oshima K, Sakata-Yanagimoto M et al (2005). High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation. Bone Marrow Transplant 36: 821-824.
3. Basara N, Kiehl MG, Fauser AA (2001). New therapeutic modalities in the treatment of graft-versus-host disease. Crit Rev Oncol Hematol 38: 129-138.
4. Boeckh M, Gooley TA, Myerson D, Cunningham T, Schoch G, Bowden RA (1996). Cytomegalovirus pp65 antigenemia-guided early treatment with anciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood 88: 4063-4071.
5. Boeckh M, Nichols WG, Papanicolaou G, Rubin R, Wingard JR, Zaia J (2003). Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol Blood Marrow Transplant 9: 543-558.
6. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J (1990). Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28: 495-503.
7. Boriskin YS, Fuller K, Powles RL et al (2002). Early detection of cytomegalovirus (CMV) infection in bone marrow transplant patients by reverse transcription-PCR for CMV spliced late gene UL21.5: a two site evaluation. J Clin Virol 24: 13-23.
8. Canto CL, Granato CF, Garcez E et al (2000). Cytomegalovirus infection in children with Down syndrome in a day-care center in Brazil. Rev Inst Med Trop Sao Paulo 42: 179-183.
9. Castagnola E, Cappelli B, Erba D, Rabagliati A, Lanino E, Dini G (2004). Cytomegalovirus infection after bone marrow transplantation in children. Hum Immunol 65: 416-422.
10. Cray C, Levy RB (1993). CD8+ and CD4+ T cells contribute to the exacerbation of class I MHC disparate graft-vs-host reaction by concurrent murine cytomegalovirus infection. Clin Immunol Immunopathol 67: 84-90.
11. Cunha AA, Marin LJ, Aquino VH, Figueiredo LT (2002). Diagnosis of cytomegalovirus infections by qualitative and quantitative PCR in HIV-infected patients. Rev Inst Med Trop Sao Paulo 44: 127-132.
12. Dominietto A, Raiola AM, van Lint MT (2001). Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose. Br J Haematol 112: 219-227.
13. Einsele H, Ehninger G, Hebart H et al (1995). Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 86: 2815-2820.
14. Gall-Troselj K, Mravak-Stipetic M, Jurak I, Ragland WL, Pavelic J (2001). Helicobacter pylori colonization of tongue mucosa - increased incidence in atrophic glossitis and burning mouth syndrome (BMS). J Oral Pathol Med 30: 560-563.
15. Gomez RS, Carneiro MA, Souza LN et al (2001). Oral recurrent human herpes virus infection and bone marrow transplantation survival. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91: 552-556.
16. Grefte A, van der Giessen M, van Son W, The TH (1993). Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J Infect Dis 167: 270-277.
17. Hebart H, Jahn G, Sinzger C, Kanz L, Einsele H (2000). CMV infection in bone marrow and solid organ transplant patients in the era of antiviral prophylaxis. Herpes 7: 13-17.
18. Heimdahl A, Mattsson T, Dahllof G, Lonnquist B, Ringden O (1989). The oral cavity as a port of entry for early infections in patients treated with bone marrow transplantation. Oral Surg Oral Med Oral Pathol 68: 711-716.
19. Hosmer DW, Lemesshow S (2000). Supplied logistic regression. 2nd edn. A Wiley-Interscience Publication: New York, 280 pp.
20. Jones M, Cray C, Levy RB (1996). Concurrent MCMV infection augments donor antihost-specific activity and alters clinical outcome following experimental allogenic bone marrow transplantation. Transplantation 61: 856-861.
21. Kalbfleisch JD, Prentice RL (2002). The statistical analysis of failure time data. 2nd edn. John Wiley & Sons: New York, 462 pp.
22. Kano Y, Shiohara T (2000). Current understanding of cytomegalovirus infection in immunocompetent individuals. J Dermatol Sci 22: 196-204.
23. Kloover JS, van den Bogaard AE, van Dam JG, Grauls GE, Vink C, Bruggeman CA (2002). Persistent rat cytomegalovirus (RCMV) infection of the salivary glands contributes to the anti-RCMV humoral immune response. Virus Res 85: 163-172.
24. Li CR, Greenberg PD, Gilbert MJ, Goodrich JM, Stanley RR (1994). Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 83: 1971-1979.
25. Machado CM, Menezes RX, Macedo MC et al (2001). Extended antigenemia surveillance and late cytomegalovirus infection after allogeneic BMT. Bone Marrow Transplant 28: 1053-1059.
26. Nichols WG, Boeckh M (2000). Recent advances in the therapy and prevention of CMV infections. Clin Virol 16: 25-40.
27. Osarogiagbon RU, Defor TE, Weisdorf MA, Erice A, Weisdorf DJ (2000). CMV antigenemia following bone marrow transplantation: risk factors and outcomes. Biol Blood Marrow Transplant 6: 280-288.
28. Piiparinen H, Hockerstedt K, Gronhagen-Riska C, Lappalainen M, Suni J, Lautenschlager I (2001). Comparison of plasma polymerase chain reaction and pp65-antigenemia assay in the quantification of cytomegalovirus in liver and kidney transplant patients. J Clin Virol 22: 111-116.
29. Sinclair J, Sissons P (1996). Latent and persistent infections of monocytes and macrophages. Intervirology 39: 293-301.
30. Söderberg C, Larsson S, Rozell BL, Sumitran-Karuppan S, Ljungman P, Moller E (1996). Cytomegalovirus-induced CD13-specific autoimmunity - a possible cause of chronic graft-vs-host disease. Transplantation 61: 600-609.
31. Takemoto Y, Takatsuka H, Wada H et al (2000). Evaluation of CMV/human herpes virus-6 positivity in bronchoalveolar lavage fluids as early detection of acute GVHD following BMT: evidence of a significant relationship. Bone Marrow Transplant 26: 77-81.
32. Torok-Storb B, Boeckh M, Hoy C, Leisenring W, Myerson D, Gooley T (1997). Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. Blood 90: 2097-2102.
33. Victória JM, Guimaraes AL, da Silva LM, Kalapothakis E, Gomez RS (2005). Polymerase chain reaction for identification of herpes simplex virus (HSV-1), cytomegalovirus (CMV) and human herpes virus-type 6 (HHV-6) in oral swabs. Microbiol Res 160: 61-65.
34. Yan SS, Fedorko DP (2002). Recent advances in laboratory diagnosis of cytomegalovirus infection. Clin Appl Immunol Rev 2: 155-167.
35. Zaia JA, Forman SJ, Gallagher MT, Vanderwal-Urbina E, Blume KG (1984). Prolonged human cytomegalovirus viremia following bone marrow transplantation. Transplantation 37: 315-317.
36. Zaia JA, Gallez-Hawkins GM, Tegtmeier BR (1997). Late cytomegalovirus disease in marrow transplantation is predicted by virusload in plasma. J Infect Dis 176: 782-785.
37. Zekri AR, Mohamed WS, Samra MA, Sherif GM, El-Shehaby AM, El-Sayed MH (2004). Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation. Transpl Immunol 13: 305-311.